在T细胞依赖性大肠炎期间,依赖HIF-2α诱导miR-29a抑制TH1活动
Agnieszka K Czopik1, Eóin N McNamee2,3, Victoria Vaughn4
1Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA. Agnieszka.K.Czopik@uth.tmc.edu.
Nature communications
|September 13, 2024
概括
低氧诱导因子 (HIF) 在炎症性肠病期间在T细胞中稳定,促进炎症. 这项研究表明,HIF-2α诱导miR-29a,抑制T助手1 (TH1) 炎症.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 胃肠病学 胃肠病学
背景情况:
- 炎症性肠病 (IBD) 具有代谢失衡的特征,导致缺氧和缺氧诱导因素 (HIF) 的稳定.
- 在肠道炎症期间,HIF在CD4+T细胞中的稳定可能通过微RNA调节改变T细胞功能.
研究的目的:
- 调查HIF稳定在CD4+T细胞在肠道炎症期间的作用.
- 确定T细胞中由HIF调节的microRNA及其对TH1-介导炎症的影响.
主要方法:
- 在实验性结肠炎模型中评估T细胞内在缺氧和HIF蛋白稳定.
- 在初级CD4+T细胞中进行microRNA查.
- 分析HIF-2α和miR-29a操纵T细胞对疾病严重性的影响.
主要成果:
- 在实验性结肠炎期间观察到T细胞特异性缺氧和HIF稳定.
- 在低氧条件下,miR-29a被确定为由HIF-2α在CD4+T细胞中调节的关键微RNA.
- 特定于T细胞的HIF-2α或miR-29a的删除加剧了肠道炎症,而它们的过度表达或模仿性传递减弱了TH1-驱动性结肠炎.
结论:
- 在CD4+T细胞中,HIF-2α对miR-29a的低氧依赖诱导在减弱TH1-介导的肠炎症中起着至关重要的作用.
- 准HIF-miR-29a轴为炎症性肠道疾病提供了潜在的治疗策略.
相关概念视频
T Cell Types and Functions
961
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
961
T Cell Activation and Clonal Selection
688
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
688
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120


